Found 108 matching trials
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Elementā¢) PHASE3 Compile acute (30-day) clinical outcomes data and 9-month angiographic and ...
Show More Location
St. Vincent's Hospital - Sydney
Learn More & Join Trial
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE VĀ® Everolimus Eluting Coronary Stent System PHASE3 The purpose of the SPIRIT IV Clinical Trial is to continue to evaluate the ...
Show More Location
Scottsdale Healthcare
Learn More & Join Trial
SPIRIT III Clinical Trial of the XIENCE VĀ® Everolimus Eluting Coronary Stent System (EECSS) PHASE3 This study is divided into 5 arms:
1. Randomized Clinical Trial (RCT): Pro...
Show More Location
Baptist Medical Center Princeton
Learn More & Join Trial
PE PREMIER CHINA CLINICAL TRIAL NA PE PREMIER China: A Prospective, Multicenter Trial to Assess the Promus PRE...
Show More Location
Multiple Locations
Learn More & Join Trial
XIENCE VĀ® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study N/A XIENCE VĀ® India is a prospective, open-label, multi-center, observational, ...
Show More Learn More & Join Trial
A Clinical Evaluation of Absorb⢠Bioresorbable Vascular Scaffold (Absorb⢠BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) NA To evaluate the safety and efficacy of the Absorb BVS System compared to th...
Show More Learn More & Join Trial
ABSORB PHYSIOLOGY Clinical Investigation NA The target enrollment goal for the trial was to enroll 36 subjects. However...
Show More Learn More & Join Trial
SPIRIT Small Vessel Registry NA To evaluate the safety and effectiveness of the 2.25 mm XIENCE VĀ® Everolimu...
Show More Location
Scottsdale Healthcare
Learn More & Join Trial
EVOLVE II QCA: A Prospective, Multicenter Trial to Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) PHASE3 The purpose of this study is to evaluate 9 month angiographic and intravasc...
Show More Location
The Prince Charles Hospital
Learn More & Join Trial
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents N/A Prospective, multicenter, registry of at least 11,000 (and up to 15,000) co...
Show More Location
Minneapolis Heart Institute
Learn More & Join Trial